Bausch + Lomb Corporation (BLCO)
15.95
-0.04 (0.25%)
Upcoming Events
Latest Headlines
Bausch + Lomb launches EyeGility preloaded IOL system in the U.S.
July 16, 2026 7:01 AM - StreetInsider
Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
July 16, 2026 7:00 AM - BizWire
Bausch + Lomb glaucoma eye drop fails Phase 2 trial
July 9, 2026 4:30 PM - StreetInsider
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
July 9, 2026 4:30 PM - BizWire
Bausch + Lomb launches AI digital health platform for eye care
July 9, 2026 7:02 AM - StreetInsider
Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
July 9, 2026 7:00 AM - BizWire
Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
July 6, 2026 7:15 AM - BizWire
Bausch + Lomb survey links dry eye treatment to emotional wellbeing
July 1, 2026 7:01 AM - StreetInsider
New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
July 1, 2026 7:00 AM - BizWire
Form 4 Bausch & Lomb Corp For: Jun 12 Filed by: Bonnefoy Luc
June 16, 2026 4:17 PM - SEC Filing
RBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share'
June 5, 2026 8:49 AM - StreetInsider
Bausch + Lomb launches preservative-free dry eye drops in US
June 1, 2026 6:59 AM - StreetInsider
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
June 1, 2026 6:59 AM - BizWire
Form 4 Bausch & Lomb Corp For: May 26 Filed by: VON ESCHENBACH ANDREW C.
May 28, 2026 5:51 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ross Thomas W. Sr.
May 28, 2026 5:51 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: ROBERTSON RUSSEL C
May 28, 2026 5:51 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: Paulson John
May 28, 2026 5:50 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: Ling Karen
May 28, 2026 5:50 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: KAVANAGH SARAH B
May 28, 2026 5:50 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: COLLIS STEVEN H
May 28, 2026 5:50 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: Bernier Nathalie D.
May 28, 2026 5:50 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 26 Filed by: Alfonso Eduardo
May 28, 2026 5:37 PM - SEC Filing
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
May 28, 2026 4:15 PM - PR NewsWire
Form 4 Bausch & Lomb Corp For: May 22 Filed by: SAUNDERS BRENT L
May 26, 2026 4:56 PM - SEC Filing
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 21, 2026 7:15 AM - BizWire
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
May 20, 2026 4:49 PM - BizWire
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
May 19, 2026 4:15 PM - PR NewsWire
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in US
May 19, 2026 7:01 AM - StreetInsider
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
May 19, 2026 7:00 AM - BizWire
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
May 13, 2026 7:00 AM - PR NewsWire
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
May 12, 2026 4:15 PM - PR NewsWire
Needham tracks April prescription trends for Alcon and Bausch + Lomb eye drugs
May 8, 2026 9:55 AM - StreetInsider
Form 4 Bausch & Lomb Corp For: May 05 Filed by: Eldessouky Sam
May 7, 2026 4:44 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 05 Filed by: Hashad Yehia
May 7, 2026 4:43 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 05 Filed by: Munsch Frederick
May 7, 2026 4:37 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: May 05 Filed by: Bonnefoy Luc
May 7, 2026 4:37 PM - SEC Filing
Bausch + Lomb launches advanced vitrectomy cutter in Europe
May 7, 2026 7:01 AM - StreetInsider
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
May 7, 2026 7:00 AM - BizWire
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
May 6, 2026 7:15 AM - BizWire
Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: ROBERTSON RUSSEL C
May 1, 2026 4:17 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: Paulson John
May 1, 2026 4:16 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: COLLIS STEVEN H
May 1, 2026 4:14 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Apr 30 Filed by: Alfonso Eduardo
May 1, 2026 4:13 PM - SEC Filing
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
April 30, 2026 7:00 AM - BizWire
Bausch & Lomb Corp. (BLCO) PT Raised to $16 at BofA Securities
April 30, 2026 4:35 AM - StreetInsider
Bausch & Lomb Corp. (BLCO) PT Lowered to $16 at Evercore ISI
April 29, 2026 5:15 PM - StreetInsider
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
April 29, 2026 4:05 PM - PR NewsWire
Bausch + Lomb Corporation (BLCO) Tops Q1 EPS by 3c, provides guidance
April 29, 2026 7:02 AM - StreetInsider
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
April 29, 2026 6:58 AM - BizWire
Form 4 Bausch & Lomb Corp For: Apr 24 Filed by: Stewart Andrew J.
April 27, 2026 4:44 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Apr 24 Filed by: Bailey A Robert D
April 27, 2026 4:42 PM - SEC Filing
Full Article List
